Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratorio Fides SA
Original Assignee
Laboratorios Martin Cuatrecasas SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Martin Cuatrecasas SAfiledCriticalLaboratorios Martin Cuatrecasas SA
Priority to ES0292700ApriorityCriticalpatent/ES292700A1/es
Publication of ES292700A1publicationCriticalpatent/ES292700A1/es
Drug withdrawal states-In the withdrawal phase following abstinence from alcohol in dependent patients propranolol has been claimed to lessen symptoms, ll 12 but no controlled comparisons with other agents have been made. heroin addiction and exerts an anti-craving effect rather than influencing
Procedimientos para la preparación de productos farmaceúticos en el momento de la inyección, suspensión o emulsión para uso terapeútico en medicina humana o veterinaria